Department of Radiology
Found 230 results
Filters: Keyword is Mice  [Clear All Filters]
2024
Lundmark F, Vorobyeva A, Liu Y, Lindbo S, Xu T, Oroujeni M, Rinne SS, Rosenström U, Garousi J.  2024.  Reduction of renal activity retention of radiolabeled albumin binding domain‑derived affinity proteins using a non‑residualizing label strategy compared with a cleavable glycine‑leucine‑glycine‑lysine‑linker.. Mol Med Rep. 29(2)
2023
Bantugan MAnn, Xian H, Solomon V, Lee M, Cai Z, Wang S, Duro MV, Kerman BE, Fonteh A, Meuret C et al..  2023.  Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness.. J Lipid Res. 64(6):100354.
Chung SK, Vargas DBurnes, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B et al..  2023.  Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.. J Nucl Med. 64(9):1439-1445.
Kiser K, Zhang J, Das ABharadwaj, Tranos JA, Wadghiri YZaim, Kim SGene.  2023.  Evaluation of cellular water exchange in a mouse glioma model using dynamic contrast-enhanced MRI with two flip angles.. Sci Rep. 13(1):3007.
Xu T, Schulga A, Konovalova E, Rinne SS, Zhang H, Vorontsova O, Orlova A, Deyev SM, Tolmachev V, Vorobyeva A.  2023.  Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.. Int J Mol Sci. 24(3)
Yang Y, Yang H, Alcaina Y, Puc J, Birt A, Vedvyas Y, Gallagher M, Alla S, Riascos MCristina, McCloskey JE et al..  2023.  Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models.. Nat Commun. 14(1):2068.
Fung EK, Zanzonico PB.  2023.  Monitoring the biodistribution of radiolabeled therapeutics in mice.. Methods Cell Biol. 180:93-111.
De Martino M, Daviaud C, Minns HE, Lazarian A, Wacker A, Costa APaula, Attarwala N, Chen Q, Choi S-W, Rabadàn R et al..  2023.  Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma.. Cancer Lett. 570:216329.
Kiser K, Zhang J, Qayyum S, W Bracken C, Kim SGene.  2023.  Simultaneous estimation of the cellular water exchange rate, intracellular volume fraction, and longitudinal relaxation rate in cancer cells.. NMR Biomed. 36(7):e4914.
Luo Y, Yamada M, N'Tumba-Byn T, Asif H, Gao M, Hu Y, Marangoni P, Liu Y, Evans T, Rafii S et al..  2023.  SPRY4-dependent ERK negative feedback demarcates functional adult stem cells in the male mouse germline†.. Biol Reprod. 109(4):533-551.
Kiser K, Zhang J, Kim SGene.  2023.  Textural Features of Mouse Glioma Models Measured by Dynamic Contrast-Enhanced MR Images with 3D Isotropic Resolution.. Tomography. 9(2):721-735.
Yang N, Wang Y, Dai P, Li T, Zierhut C, Tan A, Zhang T, Xiang JZhaoying, Ordureau A, Funabiki H et al..  2023.  Vaccinia E5 is a major inhibitor of the DNA sensor cGAS.. Nat Commun. 14(1):2898.
2022
Li Y, Rusinek H, Butler T, Glodzik L, Pirraglia E, Babich J, P Mozley D, Nehmeh S, Pahlajani S, Wang X et al..  2022.  Decreased CSF clearance and increased brain amyloid in Alzheimer's disease.. Fluids Barriers CNS. 19(1):21.
Miranda AMiguel, Ashok A, Chan RBarry, Zhou B, Xu Y, McIntire LBeth, Area-Gomez E, Di Paolo G, Duff KE, Oliveira TGil et al..  2022.  Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice.. Transl Psychiatry. 12(1):129.
Das ABharadwaj, Tranos JAndrew, Zhang J, Wadghiri YZaim, Kim SGene.  2022.  Estimation of Contrast Agent Concentration in DCE-MRI Using 2 Flip Angles.. Invest Radiol. 57(5):343-351.
Chandler CS, Bell MM, Chung SK, Veach DR, Fung EK, Punzalan B, Vargas DBurnes, Patel M, Xu H, Guo H-F et al..  2022.  Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.. Mol Cancer Ther. 21(1):125-137.
Alcaina Y, Yang Y, Vedvyas Y, McCloskey JE, Jin MM.  2022.  SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity.. Sci Rep. 12(1):20932.
Bellat V, Michel AO, Thomas C, Stokol T, Choi BB, Law B.  2022.  A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer.. Cancer Res. 82(7):1409-1422.
2021
Yang Y, McCloskey JE, Yang H, Puc J, Alcaina Y, Vedvyas Y, Gallegos AAGomez, Ortiz-Sánchez E, de Stanchina E, Min IM et al..  2021.  Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.. Cancer Immunol Res. 9(10):1158-1174.
Egan CE, Stefanova D, Ahmed A, Raja VJ, Thiesmeyer JW, Chen KJ, Greenberg JA, Zhang T, He B, Finnerty BM et al..  2021.  CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.. Thyroid. 31(10):1481-1493.
Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, Vargas DBurnes, Kubik TZ, Monette S, Santich BH et al..  2021.  Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications.. Bioconjug Chem. 32(4):649-654.
Rosenberg JB, Chen A, De BP, Dyke JP, Ballon DJ, Monette S, Arbona RJRicart, Kaminsky SM, Crystal RG, Sondhi D.  2021.  Safety of Direct Intraparenchymal AAVrh.10-Mediated Central Nervous System Gene Therapy for Metachromatic Leukodystrophy.. Hum Gene Ther. 32(11-12):563-580.
Santich BH, Cheal SM, Ahmed M, McDevitt MR, Ouerfelli O, Yang G, Veach DR, Fung EK, Patel M, Vargas DBurnes et al..  2021.  A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy.. Clin Cancer Res. 27(2):532-541.
Kelly JM, Jeitner TM, Ponnala S, Williams C, Nikolopoulou A, DiMagno SG, Babich JW.  2021.  A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα).. Mol Imaging Biol. 23(5):686-696.
2020
Cheal SM, Patel M, Yang G, Veach D, Xu H, Guo H-F, Zanzonico PB, Axworthy DB, Cheung N-KV, Ouerfelli O et al..  2020.  An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.. Bioconjug Chem. 31(3):501-506.